BRAF mutation predicts sensitivity to MEK inhibition
Memorial Sloan Kettering Cancer Center · Broad Institute · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,326
total citations
- FWCI
- 29.94
- Percentile
- 100%
- References
- 28
Citations per year
Authors
14Topics & keywords
Topics
Keywords
- Cancer research
- MEK inhibitor
- MAPK/ERK pathway
- Melanoma
- Kinase
- Signal transduction
- Mutation
- Lung cancer
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.